Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA

Journal of Rheumatology

Volumn 34, Issue 7, 2007, Pages 1528-1534

  Santiago, Mittermayer ^a   Baron, Murray ^b   Hudson, Marie ^b   Burlingame, Rufus W ^c   Fritzler, Marvin J ^d  

^a HOSPITAL SANTA IZABEL   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

^c INOVA DIAGNOSTICS INC   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoantibodies; ELISA; RNA polymerase; Systemic sclerosis

Indexed keywords

DNA DIRECTED RNA POLYMERASE III ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADDRESSABLE LASER BEAD IMMUNOASSAY; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANADA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; JOINT; KIDNEY; MALE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS; TENDON;

ANTIBODIES, ANTINUCLEAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34447523752     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Stetler DA, Rose KM, Wenger ME, et al. Antibodies to distinct polypeptides of RNA polymerase I in sera from patients with rheumatic autoimmune disease. Proc Natl Acad Sci USA 1982;79:7499-503.
2. Reimer G, Rose KM, Scheer U, Tan EM. Autoantibody to RNA polymerase 1 in scleroderma sera. J Clin Invest 1987;79:65-72.
3. Kuwana M, Kaburaki J, Mimori T, et al. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest 1993;91:1399-404.
4. Okano Y, Steen VD, Medsger TA Jr. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993;119:1005-13.
5. Kuwana M, Kaburaki J, Okano Y, et al. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994;37:75-83.
6. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
7. Bunn CC, Denton CP, Shi-Wen X, et al. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 1998;37:15-20.
8. Meyer OC, Fertig N, Lucas M, et al. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007;34:104-9.
9. Okano Y, Medsger TA Jr. RNA polymerase I-III autoantibodies. In: Peter JB, Shoenfeld Y, editors. Autoantibodies. Amsterdam: Elsevier Science BV; 1996:727-34.
10. Kuwana M, Kimura K, Kawakami Y. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera - Application to enzyme-linked immunosorbent assay. Arthritis Rheum 2002;46:2742-7.
11. Kuwana M, Okano Y, Pandey JP, et al. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum 2005;52:2425-32.
12. Yamasaki Y, Honkanen-Scott M, Hernandez L, et al. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies. Arthritis Rheum 2006;54:3051-6.
13. Medsger TA Jr, Bombardieri S, Czirjak L, et al. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003;21:S42-S46.
14. Medical Research Council. Aids to the examination of the peripheral nervous system. London: Her Majesty's Stationery Office, Memorandum no. 45; 1976.
15. Arnett FC, Reveille JD, Goldstein R, et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): An immunogenetic, serological and clinical analysis. Arthritis Rheum 1996;39:1151-60.
16. Chang M, Wang RJ, Yangco DT, et al. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purified RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin Immunol Immunopathol 1998;89:71-8.
17. Bardoni A, Rossi P, Salvini R, et al. Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. Clin Exp Rheumatol 2003;21:301-6.
18. Kuwana M, Okano Y, Kaburaki J, et al. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994;37:902-6.
19. Peene I, Meheus L, Veys EM, De Keyser F. Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis 2002;61:1090-4.
20. Amoura Z, Piette J-C, Bach J-F, Koutouzov S. The key role of nucleosomes in lupus. Arthritis Rheum 1999;42:833-43.
21. Ghillani-Dalbin P, Amoura Z, Cacoub P, et al. Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients. Lupus 2003;12:833-7.
22. Villalta D, Tozzoli R, Bizzaro N, et al. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Ann NY Acad Sci 2005;1050:176-84.
23. Suer W, Dahnrich C, Schlumberger W, Stocker W. Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes. J Autoimmun 2004;22:325-34.
24. Reimer G, Steen VD, Penning CA, et al. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988;31:525-32.